FDA PMA FDA Class 2 Approved 🇺🇸 United States

Intervertebral Fusion Device With Bone Graft, Lumbar

PMA: P980048 · Supplement: S003 · Decision Oct 6, 2004
Classifications
1
FEI Numbers
422
Registration Numbers
422

Basic Information

Device Name
Intervertebral Fusion Device With Bone Graft, Lumbar
Trade Name
BAK/C VISTA CERVICAL INTERBODY FUSION DEVICE
PMA Number
P980048
Supplement Number
S003
Device Class
FDA Class 2
Product Code
MAX
Generic Name
Intervertebral fusion device with bone graft, lumbar
Regulation Number
888.3080
Medical Specialty
Orthopedic
Advisory Committee
Orthopedic
Decision
Approved
Decision Code
APPR
Decision Date
October 6, 2004
Date Received
April 12, 2004
Supplement Type
Normal 180 Day Track
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

APPROVAL FOR THE BAK/C VISTA DEVICE, A MODIFICATION TO THE ALREADY APPROVED BAK/C DEVICE. THE BAK/C VISTA DIFFERS FROM THE BAK/C DEVICE IN THE FOLLOWING MANNERS: 1) THE BAK/C VISTA HAS TWO LARGE OFFSET SUPERIOR-INFERIOR (SI) HOLES FOR BONE INGROWTH WHEREAS THE BAK/C HAS MANY SMALL HOLES AT VARIOUS CIRCUMFERENTIAL AND LONGITUDINAL LOCATIONS, AND 2) THE BAK/C VISTA IS MADE OF PEEK OPTIMA LT1 AND THE BAK/C IS MADE OF TITANIUM (TI-6A1-4V). THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME BAK/C VISTA AND IS INDICATED FOR USE IN SKELETALLY MATURE PATIENTS WITH DEGENERATIVE DISC DISEASE DDD) OF THE CERVICAL SPINE WITH ACCOMPANYING RADICULAR SYMPTOMS AT ONE DISC LEVEL. DDD IS DEFINED AS DISCOGENIC PAIN WITH DEGENERATION OF THE DISC CONFIRMED BY HISTORY AND RADIOGRAPHIC STUDIES. BAK/C IMPLANTS ARE USED TO FACILITATE FUSION IN THE CERVICAL SPINE AND ARE PLACED VIA AN ANTERIOR APPROACH AT THE C-3 TO C-7 DISC LEVELS USING AUTOGRAFT BONE.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MAX Intervertebral Fusion Device With Bone Graft, Lumbar